semaglutide risk Effect of 2.4 mg once weekly on 10‐year type 2 diabetes in adults with overweight or obesity - Wilkinson - 2023 - Obesity Semaglutide GLP-1 vs Ozempic vs

GLP-1R Signaling Directly Activates Arcuate Nucleus Kisspeptin Action in Brain Slices but Does not Rescue Luteinizing Hormone Inhibition in Ovariectomized Mice During Negative Energy Balance

Some GLP-1 medications are used for diabetes management, while others are approved specifically for chronic weight management

no controlled trials have directly compared continuous vs cyclic dosing in healthy adults

Semaglutide has been linked to gastroparesis (stomach paralysis), bowel obstruction , and vision loss

As of February 2025, injectable semaglutide is no longer on the FDAs drug shortages list, so compounding pharmacies must stop producing it by May 2025 at the latest

Curr Drug Targets (2006) 7(11):143541.10.2174/1389450110607011435 87 HuMWuHChaoC